Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia.
Georges JL, Gilles F, Cochet H, Bertrand A, De Tournemire M, Monguillon V, Pasqualini M, Prevot A, Roger G, Saba J, Soltani J, Koukabi-Fradelizi M, Beressi JP, Laureana C, Prost JF, Livarek B. Georges JL, et al. Among authors: prost jf. PLoS One. 2020 Dec 21;15(12):e0244349. doi: 10.1371/journal.pone.0244349. eCollection 2020. PLoS One. 2020. PMID: 33347477 Free PMC article.
Preclinical pharmacology of milnacipran.
Briley M, Prost JF, Moret C. Briley M, et al. Among authors: prost jf. Int Clin Psychopharmacol. 1996 Sep;11 Suppl 4:9-14. doi: 10.1097/00004850-199609004-00002. Int Clin Psychopharmacol. 1996. PMID: 8923122 Review.
Efficacy and tolerability of milnacipran: an overview.
Montgomery SA, Prost JF, Solles A, Briley M. Montgomery SA, et al. Among authors: prost jf. Int Clin Psychopharmacol. 1996 Sep;11 Suppl 4:47-51. doi: 10.1097/00004850-199609004-00007. Int Clin Psychopharmacol. 1996. PMID: 8923127 Review.
Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3.
Le Clorennec C, Bazin H, Dubreuil O, Larbouret C, Ogier C, Lazrek Y, Garambois V, Poul MA, Mondon P, Barret JM, Mathis G, Prost JF, Pèlegrin A, Chardès T. Le Clorennec C, et al. Among authors: prost jf. Mol Cancer Ther. 2017 Jul;16(7):1312-1323. doi: 10.1158/1535-7163.MCT-16-0886. Epub 2017 May 15. Mol Cancer Ther. 2017. PMID: 28507002 Free article.
The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells.
Estupina P, Fontayne A, Barret JM, Kersual N, Dubreuil O, Le Blay M, Pichard A, Jarlier M, Pugnière M, Chauvin M, Chardès T, Pouget JP, Deshayes E, Rossignol A, Abache T, de Romeuf C, Terrier A, Verhaeghe L, Gaucher C, Prost JF, Pèlegrin A, Navarro-Teulon I. Estupina P, et al. Among authors: prost jf. Oncotarget. 2017 Jun 6;8(23):37061-37079. doi: 10.18632/oncotarget.15715. Oncotarget. 2017. PMID: 28427157 Free PMC article.
71 results